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Background. Persistent sleep disturbances are one of the most common symptoms of Major 
Depressive Disorder (MDD) in adolescence. These are not typically targeted in psychological 
treatments and it is not known if psychological treatment for depression improves sleep.  
Methods. Secondary analyses were conducted using data from a large, multi-centre, 
randomised controlled trial (Goodyer et al., 2017b). Young people aged 12-18 years (N = 
465; 75% female) met diagnostic criteria for Major Depressive Disorder, based on the 
Kiddie-Schedule for Affective Disorders and Schizophrenia (K-SADS). They were 
randomised to one of three psychological treatments. Sleep difficulties were assessed at 
baseline, post-treatment (36 weeks) and one year follow up (86 weeks) with the K-SADS, 
and the Mood and Feelings Questionnaire (MFQ).  
Results. At baseline, 92% of young people exhibited clinically significant sleep difficulties. 
Exploratory analyses suggest that sleep difficulties significantly decreased from baseline to 
end of treatment on self-report and interview-based measures, and this decrease was 
maintained at follow up. Reduction in sleep difficulties did not differ between the 
psychological treatments. Approximately, half of young people reported residual sleep 
difficulties at the end of treatment and at follow-up.  
Limitations. This paper reports secondary data analyses and findings are exploratory.  
Conclusions. Tentative results suggest that psychological treatments for depression reduced 
sleep problems for some participants. However, young people with treatment-resistant sleep 
problems may benefit from adjunctive sleep interventions. Future work with a range of sleep 
measures is needed to determine those who have residual sleep problems at the end of 
treatment and post-treatment follow-up. 




Sleep problems are common in teenagers (Gradisar, Gardner, & Dohnt, 2011; 
Ohayon, Roberts, Zulley, Smirne, & Priest, 2000). These are believed to be due to a range of 
social factors and to changes in the circadian rhythm during puberty (Owens, 2014). 
Common sleep difficulties amongst the general adolescent population typically include 
insufficient sleep (Eaton et al., 2010) and weekday-to-weekend sleep variability (Wittmann, 
Dinich, Merrow, & Roenneberg, 2006). Sleep problems can become chronic and persistent 
during adolescence (Sivertsen, Harvey, Pallesen, & Hysing, 2017), and can be linked to poor 
emotional and physical health and impaired functioning at home and school (Shochat, Cohen-
Zion, & Tzischinsky, 2014), as well as being distressing and disruptive for the whole family 
(Wake et al., 2006).  
These persistent sleep problems are often experienced by individuals with worry and 
low mood (Gregory & O'Connor, 2002). As part of a diagnosis of Major Depressive Disorder 
(MDD), adolescents are required to present with at least one ‘core’ symptom, and a selection 
of further additional symptoms. One of the possible additional symptoms is ‘sleep 
disturbance’, and this has been found to be one of the most common symptoms of depression 
in adolescents (Orchard, Pass, Marshall, & Reynolds, 2017). The ‘sleep disturbance’ 
symptom is broken down into depression-specific sleep difficulties, including insomnia (not 
being able to get to sleep), hypersomnia (sleeping too much), circadian reversal (being active 
at night and sleeping during the day) and non-restorative sleep (not feeling rested after sleep ) 
(APA, 2000). This range of difficulties are not typically experienced by the general 
adolescent population, or by adolescents with other common mental health problems such as 
anxiety, where individuals primarily experience difficulties with insomnia (Alfano, Ginsburg, 
& Kingery, 2007). Furthermore, depressed young people who report problems with sleep 
have been found to be more likely to have severe depression (Liu et al., 2007) and to have 
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thoughts about death and suicide (Urrila et al., 2012) than those who do not have problems 
sleeping. Sleep disturbances have also been found to be a common residual symptom among 
depressed adolescents (Kennard et al., 2006) and adults (Carney, Segal, Edinger, & Krystal, 
2007; Nierenberg et al., 2010), and residual insomnia has been found to increase the risk of 
depression recurrence (Dombrovski et al., 2008). 
Some authors have suggested that sleep problems are not just a symptom or a by-
product of depression, but that they may contribute to the onset or maintenance of depression  
(Clarke & Harvey, 2012). Most of this work specifically examines insomnia. This is mainly 
because insomnia is considered the most common sleep disorder in youth (e.g. Johnson, 
Roth, Schultz, & Breslau, 2006; Ohayon et al., 2000), and because insomnia treatments are 
well-established i.e. Cognitive-Behavioural Therapy for Insomnia (CBTi). There is also 
evidence that sleep difficulties in children and young people are likely to predict the risk of 
developing depression in later childhood or adulthood (de Bruin, Bögels, Oort, & Meijer, 
2015; Gradisar et al., 2011; Roane & Taylor, 2008; Roberts & Duong, 2013). There may be 
different causal pathways or common factors associated with the onset of both sleep 
problems and depression, for example physical problems linked to chronic illnesses (e.g. 
pain, problems breathing), or negative life events or adverse socio-economic circumstances. 
This possible causal relationship, and the focus on insomnia, has led to the proposal of 
specific guidelines for treating ‘insomnia’ in adolescence, i.e. drawing on techniques from 
CBTi (Clarke & Harvey, 2012). It is also important to note that while sleep disturbance is a 
diagnostic criterion for MDD, sleep disorders (specifically insomnia disorder and delayed 
sleep-wake phase disorder) are conceptualised as independent diagnostic entities (Staner 
2010) and are often comorbid with depression (Buysse et al., 2008).  
Psychological interventions based on cognitive behavioural models of insomnia are an 
effective treatment for sleep problems in adults (Koffel, Koffel, & Gehrman, 2015; Trauer, 
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Qian, Doyle, Rajaratnam, & Cunnington, 2015) and adolescents (de Bruin et al., 2015), 
including those with a range of mental health problems (van Straten et al., 2017; Wu, 
Appleman, Salazar, & Ong, 2015). Sleep interventions can be delivered in a variety of ways, 
including via computer (Cheng & Dizon, 2012), thus significantly increasing access to 
treatment. A recent meta-analysis of non-pharmacological sleep interventions also found that 
treatment for sleep problems significantly reduced symptoms of depression (Gee et al., 2018), 
even though the interventions did not address any other aspects of depression including core 
symptoms of e.g. low mood or anhedonia. The effect of sleep interventions on depression 
symptoms was larger in studies that recruited participants with current mental health 
difficulties (and hence more severe symptoms of depression). There was however limited 
research on the effect of treating sleep problems on depression in children and adolescents.    
Just as treatment for sleep problems may improve symptoms of depression, so it is 
plausible that treatment for depression may improve sleep difficulties, particularly given that 
sleep difficulties are one of the symptoms used to diagnose Major Depressive Disorder 
(DSM-V; APA, 2013; ICD-10; WHO, 1992). Although sleep problems are extremely 
common amongst depressed young people (Orchard et al., 2017), most standardised manuals 
for psychological treatments for depression do not typically include sleep intervention 
techniques (e.g. Brent & Poling, 1997; Martell, Addis, & Jacobson, 2001; Ritschel, Ramirez, 
Jones, & Craighead, 2011). However, the improvement of other symptoms of depression may 
have an indirect benefit on sleep. For example, perseverative and ruminative thinking is 
common in depression and is hypothesised to interfere with sleep onset (Lovato & Gradisar, 
2014). Therefore, reducing perseverative and ruminative thinking may help make sleep onset 
more rapid. In addition, subjective report of specific sleep problems may be inflated by 
negative cognitive biases or self-critical thinking, which are pervasive in depression in adults 
(Joorman, Yoon, & Zetsche, 2007) and adolescents (Orchard, Pass, & Reynolds, 2016; Platt, 
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Waters, Schulte-Koerne, Engelmann, & Salemink, 2017). Objective and subjective 
measurements of sleep are poorly correlated amongst depressed individuals (Bertocci et al., 
2005; Dahl & Puig-Antich, 1990) and this may be explained by potential reporting biases, 
such as misperception of sleep deficit, cognitive inflexibility, and selective attention and self-
monitoring (Hiller, Johnston, Dohnt, Lovato, & Gradisar, 2015), which are likely to be 
amplified by low mood and worry. Successful treatment for depression reduces the associated 
negative cognitive biases (Tang, DeRubeis, Beberman, & Pham, 2005) and this may lead to 
more favourable reports of sleep quality (Lofthouse, Gilchrist, & Splaingard, 2009).  
It was recently found that cognitive-behavioural therapy for anxiety in children and 
adolescents improved self-reported sleep problems (Peterman et al., 2016). However, this 
was only found for parent report, not child report. The authors also noted that child-reported 
sleep problems were low in this sample. Surprisingly, given the high prevalence of sleep 
problems in adolescents with depression, and the adverse impact of sleep difficulties, 
research has not yet examined whether treatments for adolescent depression improve sleep 
problems. Although there is evidence that CBT for insomnia reduces insomnia and may have 
an added benefit of reducing symptoms of depression, it is not known if CBT for depression 
improves sleep disturbances, or what effect other psychological treatments for depression 
have on sleep disturbances e.g. via reduction in other underlying common factors.   
This paper reports on the exploratory post-hoc analyses of data from a randomised 
controlled trial for adolescent depression where there was high baseline prevalence of sleep 
symptoms (Goodyer et al., 2017b). Given the absence of evidence on this important subject, 
the aim of this study is twofold: first to describe the nature of sleep problems in a large 
sample of young people with depression, and second to examine the effect of three distinct 
psychological treatments for adolescent depression on sleep problems, measured by self-
report depression questionnaires and diagnostic interviews.  
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Methods 
Participants and Recruitment 
 Young people in this study were taking part in a large, multi-centre, randomised 
controlled trial; the HTA-funded IMPACT (Improving Mood through Psychoanalytic and 
Cognitive-Behavioural Therapy) Study (Goodyer et al., 2017b). IMPACT is a pragmatic 
superiority trial comparing the relative clinical and cost effectiveness of three psychological 
treatments for adolescent Major Depressive Disorder. Participants were recruited and treated 
at 15 National Health Service child and adolescent mental health service (CAMHS) clinics in 
three regions of England. 
A total of 465 young people were randomised to one of three treatment approaches; 
Short-Term Psychoanalytic Psychotherapy (STPP); Cognitive Behavioural Therapy (CBT); 
and a manualised form of specialist clinical care termed Brief Psychosocial Intervention 
(BPI) which was chosen as the active control treatment. Lengths of treatment varied for the 
three approaches: 28 sessions over 30 weeks for STPP; 20 sessions over 30 weeks for CBT; 
and 12 sessions over 20 weeks for BPI. The three treatments were based on distinct 
theoretical models and were delivered in routine services by specialist clinicians according to 
treatment manuals (IMPACT Study CBT Sub-Group, 2010; IMPACT Study Child 
Psychotherapy Sub-Group, 2010; Kelvin et al., 2010). CBT and STPP manuals did not 
specifically consider how to address problems with sleep. The BPI manual identified sleep 
hygiene as a routine intervention that clinicians could offer. Treatment manuals were 
developed for each modality and via examination of treatment adherence using the 
Comparative Psychotherapy Process Scale (Hilsenroth, Blagys, Ackerman, Bonge, & Blais, 
2005), treatment fidelity was found to be good, (Midgley et al., 2018).  
The mean age of participants was 15.6 years (SD = 1.4) and 348 (75%) were female. 
Most (85%) described their ethnicity as White British. Participants were recruited to the study 
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and treated in 15 Child and Adolescent Mental Health services in the UK. All participants 
met diagnostic criteria for moderate to severe Major Depressive Disorder, based on the K-
SADS (see below; Kaufman et al., 1997).  
The study was approved by the Cambridgeshire 2 Research Ethics Committee 
(reference 09/H0308/137) and local NHS provider trusts. All patients and their parents gave 
written informed consent. See Goodyer et al. (2017a) for comprehensive information on the 
recruitment process and study design. 
Measures and Procedure 
 Two measures were used to address the aims of this study: the interviewer 
administered Kiddie-Schedule for Affective Disorders and Schizophrenia (K-SADS-PL; 
Kaufman et al., 1997) and the adolescent version of the self-report Mood and Feelings 
Questionnaire (MFQ; Costello & Angold, 1988). The present analyses report data from three 
time points from the IMPACT trial: baseline, post-treatment (36 weeks after randomisation), 
and at one-year follow-up (86 weeks after randomisation). Time between randomization and 
first session varied as treatments were delivered in routine clinical practices. Median number 
of weeks across location and treatment ranged from 2.9 weeks to 7.3 weeks (Goodyer et al., 
2017a). 
 The Kiddie-Schedule for Affective Disorder and Schizophrenia Present and Lifetime 
(K-SADS-PL) version is a semi-structured interview measure, which was used to establish 
the presence of DSM-IV diagnoses. Adolescents and parents/guardians completed the 
measure and both interviews were used to construct a diagnosis based on positive symptom 
reporting from either respondent. See Goodyer et al. (2017b) for information regarding inter-
rater reliability. The K-SADS DSM-IV Major Depressive Disorder section examines the 
presence or absence of all symptoms of depression in the past two weeks. Six sleep 
disturbance symptoms are assessed in this section: ‘initial insomnia’, ‘middle insomnia’, 
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‘terminal insomnia’, ‘hypersomnia’, ‘circadian-reversal’ and ‘non-restorative sleep’. Specific 
thresholds are provided by the manual to establish when participants meet criteria for each 
sleep symptom. For example, ‘initial insomnia’ = two hours or more to fall asleep, most 
nights. The presence of individual disturbances, as well as the total number of disturbances, is 
reported in the analyses. The latter is used as in indication of severity of overall sleep 
disturbance. 
 The Mood and Feelings Questionnaire (MFQ) is a 33-item self-report measure 
completed by the adolescent, examining depressive symptoms present over the past two 
weeks. The instrument is designed to cover symptom areas specified in DSM-IV for an 
episode of MDD, e.g. sleep disturbance. To be consistent with other measures in the 
IMPACT study, the MFQ was scored on a four-point scale (0-3). Ratings of ‘2’ and ‘3’ were 
then combined to be in line with typical MFQ scoring procedures. The MFQ has good test–
retest reliability (Pearson’s r = 0.78), an α coefficient of 0.82 and discriminant validity for 
detecting an episode of Major Depressive Disorder in clinical adolescent samples. Of 
particular interest in this paper are the two sleep items: ‘I didn’t sleep as well as I usually 
sleep’ and ‘I slept a lot more than usual’. These items are designed to tap into the two key 
DSM Major Depressive Disorder sleep symptoms; respectively insomnia and hypersomnia 
(APA, 2013). For the purpose of this report, these scores will be referred to as the ‘insomnia’ 
and ‘hypersomnia’ items.    
Results 
Data Preparation and Preliminary Analyses 
Missing data at the end of treatment and follow-up was higher than expected 
(Goodyer et al., 2017b), with 392 (84%) participants with available data for the primary 
outcome of MFQ scores by the end of follow-up. As such, multiple imputation (Rubin, 1987; 
Sinharay, Stern, & Russell, 2001) was used to create 20 complete data sets (N=465). The 
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original and imputed data for repeated measures analyses were reanalysed using multilevel 
modelling and no difference in patterns of significance was found. The original data are 
reported for simplicity. 
Continuous data were screened in relation to the assumptions of parametric tests 
(Tabachnick & Fidell, 2007). Where assumptions were violated, confirmatory analyses were 
conducted by running analyses with 1000 bootstrap samples or non-parametric alternatives. 
All results were consistent, suggesting that the original analyses were robust to the violations 
of assumptions, so results based on the original (non-bootstrapped) analyses are presented for 
simplicity.  
All medication use was recorded at baseline, and participants were required to be on a 
stable dose of antidepressants to take part in the trial. Of participants included in this study, 
20.1% were taking antidepressants. Only one participant identified taking a sleeping 
medication (melatonin). Between-group differences for participants with and without 
medication for depression or anxiety were examined, no between-group differences were 
identified, and all participants were included in the following analyses. For further 
information on medication use and association with clinical characteristics in the present 
sample, see Cousins et al. (2016).  
Descriptive Statistics of the Nature of Sleep Problems at Baseline 
At baseline, 92% of young people described sleep difficulties that met threshold for a 
symptom on the K-SADS (Goodyer et al., 2017b). The most commonly reported problems at 
baseline were non-restorative sleep and initial insomnia, which were both reported by over 
half of the participants (Table 1). It was also common for adolescents to report more than one 
type of sleep disturbance (see Table 2), with 58% of young people reporting 1-2 distinct sleep 
problems, and 35% of young people reporting between three and six different sleep problems. 
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There were no differences between treatment groups for frequency of baseline sleep 
problems, F(2,465) = 0.53, p = 0.59, p < 0.01. 
 
[Insert Table 1] 
 
Pre- to Post-Treatment Change in Sleep Disturbance on Self-Report Questionnaire  
First we examined subjective ratings of sleep problems (insomnia and hypersomnia) 
on the adolescent MFQ at baseline, post-treatment and follow-up. To test the effects of time 
and treatment modality, two mixed model ANOVAs were conducted with a between-subjects 
independent variable of treatment arm, with three levels (BPI, STPP, and CBT), and a within 
subjects independent variable of time, with three levels (baseline, end of treatment and 
follow-up), examining mean scores for the insomnia and hypersomnia items (see Figure 1).  
For insomnia there was a significant main effect of time, V = 0.43, F(2, 274) = 
103.54, p <.001, p = 0.43, with ratings decreasing from baseline to follow up (Figure 1).  
Pairwise comparisons revealed a significant difference in insomnia between baseline and end 
of treatment (p < .001), and baseline and follow up (p < .001), but no difference between 
insomnia at the end of treatment and at follow-up (p =.23). There was no significant main 
effect of treatment modality on young people’s ratings of insomnia, F(2, 275) = 0.27, p = .77, 
p < 0.01. There was also no significant interaction between time and treatment arm, V = 
.02, F(4, 550) = 1.20, p = .31, p < 0.01.  
Hypersomnia was reported infrequently on the MFQ (see Figure 1). There was no 
effect of time, V = .01, F(2, 275) = 0.63, p = .53, p = 0.01, treatment, F(2, 276) = 0.20, p = 
.82, p < 0.01, or time by treatment interaction V < .01, F(4, 552) = 0.12, p = .98, p < 
0.01, on ratings of hypersomnia.  
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[Insert Figure 1] 
  
Pre- to Post-Treatment Change in Sleep Disturbance on Diagnostic Interview  
Next, we examined symptom reports of sleep on the K-SADS clinical interview at 
baseline, post treatment and follow up (see Table 2). To assess if the number of sleep 
symptoms reduced over the course of psychological treatment for depression, we used a 
mixed model ANOVA with a between subjects independent variable of treatment with three 
levels (BPI, STPP, and CBT), and a within subjects independent variable of time with three 
levels (baseline, end of treatment and one year follow-up).  
The number of sleep problems was significantly lower after treatment for depression 
F(1.90, 390.61) = 106.70, p < .001. Pairwise comparisons revealed a significant reduction in 
the number of sleep problems reported between baseline and end of treatment (p < .001), and 
baseline and follow up (p < .001), but not between end of treatment and follow-up (p =.06). 
There was not a significant main effect of treatment arm, F(2, 206) = 0.43, p = .65 on the 
number of sleep problems reported and no significant interaction between treatment arm and 
time, F(3.79, 390.61) = 1.13, p = .34. 
 
[Insert Table 2] 
 
Residual Sleep Problems 
In the original trial, 31-44% of adolescents were still experiencing Major Depressive 
Disorder at the end of treatment (across the treatment arms), with 26-29% still experiencing a 
diagnosis at one year follow-up (Goodyer et al., 2017b). 
 
[Insert Table 3] 
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There was a marked reduction in the frequency of sleep problems after treatment (see 
Tables 1 and 2); however approximately half of young people reported residual sleep 
difficulties at the end of treatment and at follow-up. Furthermore, of the overall sample, 33% 
recovered from depression at 36 weeks but had residual problems with sleep (Table 3).  
Discussion 
 The results of this study show that sleep problems were virtually universal amongst a 
large sample of depressed adolescents and that, for some young people, psychological 
treatments for depression appeared to improve their sleep. Although a range of different sleep 
disturbances were reported as part of the diagnostic interview for depression, the most 
common difficulties were initial insomnia (difficulty falling asleep) and non-restorative sleep 
(not feeling rested after sleeping). No differences in recovery of sleep disturbance were found 
between the three psychological therapies (CBT, STPP and BPI). These data were collected 
from a clinically referred group of young people, with moderate to severe Major Depressive 
Disorder, who were referred to and treated in routine mental health services.  
These exploratory analyses indicate that according to a structured diagnostic interview 
for depression, approximately half of the young people did report a reduction in sleep 
disturbances after treatment for depression. An overall improvement was also reflected in a 
self-report questionnaire item measuring difficulty getting to sleep. However, this means that 
a substantial proportion continued to meet threshold for sleep disturbances at the end of 
treatment and this proportion did not change over the year of follow up. Furthermore, one 
third of young people recovered from their Major Depressive Disorder diagnosis, but still 
reported residual sleep problems after treatment and at follow up.  
Given that sleep difficulties have such adverse, lasting effects on physical and 
psychological well-being for the individual (Shochat et al., 2014), can be disruptive for the 
 15 
family (Wake et al., 2006) and may play a causal role in the development of depression 
(Lovato & Gradisar, 2014), residual sleep problems may constitute a significant on-going risk 
and may benefit from direct intervention. It is however also possible that for individuals that 
recover from depression but not from sleep disturbances, that sleep problems and depression 
may be distinct and not causally related. 
With regards to the individuals that recover from depression and sleep disturbance, 
the nature of the present data and analyses makes it difficult to determine if psychological 
treatments improve sleep and depression independently, or if improvement in sleep is simply 
a bi-product of recovering from depression. Negative cognitive processes such as 
perseverative and ruminative thinking are pervasive present in MDD, and are hypothesised to  
interfere with sleep onset (Lovato & Gradisar, 2014). Therefore, reducing perseveration and 
rumination may help make sleep onset more rapid. In addition, the negative information 
processing biases that are characteristic of MDD in adults (Joorman, Yoon, & Zetsche, 2007) 
and adolescents (Orchard, Pass, & Reynolds, 2016; Platt, Waters, Schulte-Koerne, 
Engelmann, & Salemink, 2017) may lead to inflated self-report of specific sleep problems 
and adolescents.  
There is reasonable evidence that interventions for sleep problems are effective and 
cost effective (Koffel et al., 2015; Trauer et al., 2015), can be delivered in different ways and 
made accessible through online treatment programmes (Cheng & Dizon, 2012), and that they 
significantly reduce symptoms of depression (Gee et al., 2018). This evidence has mostly 
been collected with adults, with much less evidence that similar interventions are effective for 
young people, or that they are acceptable to young people or their parents. However, 
feasibility and pilot work in this area is growing, with recent research reporting on case 
studies of CBT for insomnia (CBTi) with depressed adolescents (Orchard, Pass, Chessell, 
Moody, Ellis & Reynolds, in press) and the assessment of the feasibility of delivering web-
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based CBTi in child and adolescent mental health services in the UK (Cliffe, Croker, Denne, 
& Stallard, 2018). Further work is needed to establish the effectiveness of psychological 
interventions targeting sleep in depressed young people.  
The young people in this study were randomised to receive one of three different 
psychological interventions for depression, Cognitive Behaviour Therapy (CBT), Short Term 
Psychodynamic Psychotherapy (STPP), or Brief Psychosocial Intervention (BPI). CBT and 
STPP did not target sleep problems but BPI did include advice about sleep hygiene. Young 
people in all three arms reported significantly fewer problems with sleep after treatment and 
one year later and there was no difference between the three treatments in the reduction of 
sleep problems. This equivalence between treatments in reducing sleep problems is consistent 
with the effects of the treatments for depression severity, for which there was no significant 
differences in effectiveness or cost effectiveness between the three treatments (Goodyer et al., 
2017b). Although BPI included some material on sleep hygiene, it is unsurprising that this 
treatment did not result in greater reduction of sleep disturbance given that 1) the evidence 
suggests sleep hygiene is not one of the active components of CBT for insomnia, 2) there is 
no evidence of sleep hygiene improving insomnia, and 3) in many cases sleep hygiene is used 
as a control treatment (e.g. Stepanski & Wyatt, 2003; Taylor & Roane, 2010). It is however 
important to acknowledge that the conclusions regarding treatment are limited by the absence 
of a waitlist control group and sleep problems may naturally improve over time for some 
individuals.  
A major limitation of this study is the measurement of sleep. This limitation is 
somewhat attenuated by using two different measures of sleep – one based on a structured 
diagnostic interview by a trained assessor, the other a response to single items on a self-report 
questionnaire. However, because depression is associated with pervasive negative cognitive 
biases, perceived sleep quality may be a distortion of actual sleep quality and adolescents 
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with depression may therefore significantly over-estimate their sleep problems. Similarly, 
reported improvements in sleep after treatment for depression may reflect a change in mood 
and hence perceptions of sleep, rather than any objective change in sleep quality or duration. 
Future work in this area should include validated questionnaire and diary measures of sleep 
(e.g. Insomnia Severity Index, Pittsburgh Sleep Quality Index, Consensus Sleep Diary) as 
well as measures that do not rely on self-report (e.g. actigraphy or polysomnography). The 
addition of a direct index of sleep duration, sleep variability, wakefulness, time to sleep and 
time awake, would help unpack the meaning of these data and untangle the subjective 
experience of depression and low mood, and perceived poor sleep quality.  
It is also important to note that there are challenges with considering the role of sleep 
problems as both symptom and causal factor in depression. There is a growing body of 
literature suggesting that sleep problems and depression may both be caused by a separate 
underlying factor e.g. rumination (Lovato & Gradisar, 2014), with a recent review 
considering a wide range of mechanisms which could result in associations between 
depression, anxiety and insomnia (Blake et al., 2018).  
Relatedly, future work should also look to diagnose comorbid sleep disorders in 
addition to depressive disorders, as it is likely that some adolescents with MDD may also 
have comorbid insomnia disorder, or other sleep disorders. In the present study, residual sleep 
symptoms may indicate untreated sleep disorders. With some emerging evidence that 
disorders of insomnia and depression may have distinct characteristics (Buysse et al., 2008), 
it is important that these comorbidities are examined directly when evaluating treatment 
outcomes for depression and sleep.  
This is the first study to examine recovery of sleep disturbance following 
psychological treatment for depression in adolescence. Despite methodological shortcomings, 
we present important preliminary data that has clear treatment implications as well as 
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highlighting important ways in which we can improve assessment of sleep problems in the 
context of depression. These clinical data highlight the almost universal and adverse impact 
of sleep difficulties amongst depressed young people. Findings suggest that approximately 
half of young people treated for depression will continue to experience residual sleep 
problems, and a third of young people will experience residual sleep problems even in 
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Table 1. Frequency of K-SADS sleep disturbances at baseline, end of treatment and follow-
up  
% Baseline 
(n = 465) 
End of Treatment (36 weeks) 
(n = 270) 
Follow-up (86 weeks) 
(n = 282) 
Initial Insomnia 53.3 24.2 20.9 
Middle Insomnia 32.5 11.9 11.5 
Terminal Insomnia 17.6 14.4 10.2 
Circadian Reversal  23.9 12.8 13.3 
Non-Restorative 68.0 27.0 18.0 
Hypersomnia 15.1 9.7 11.9 





Table 2. Frequency of K-SADS sleep disturbances at baseline, end of treatment and follow-





(n = 465)  
End of Treatment (36 weeks) 
(n = 270) 
Follow-up (86 weeks) 
(n = 282) 
0  8 44 53 
1-2 58 44 37 
3-4 32 11 10 




Table 3. Frequencies of participants with and without a diagnosis of depression and residual 
sleep symptom at post-treatment (n = 270) 
 
  Major Depressive Disorder 
  Yes No 
Sleep Symptom Yes 62 (23.0%) 88 (32.6%) 






Figure 1. Mean MFQ item ratings of insomnia and hypersomnia items at baseline (n = 462), 
end of treatment (n = 317) and 1-year follow-up (n = 349) 
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